Abstract:Lasso peptides, biologically active molecules with a distinct structurally constrained knotted fold, are natural products belonging to the class of ribosomally-synthesized and posttranslationally modified peptides (RiPPs). Lasso peptides act upon several bacterial targets, but none have been reported to inhibit the ribosome, one of the main antibiotic targets in the bacterial cell. Here, we report the identification and characterization of the lasso peptide antibiotic, lariocidin (LAR), and its internally cyclized derivative, lariocidin B (LAR-B), produced by Paenabacillussp. M2, with broad-spectrum activity against many bacterial pathogens. We show that lariocidins inhibit bacterial growth by binding to the ribosome and interfering with protein synthesis. Structural, genetic, and biochemical data show that lariocidins bind at a unique site in the small ribosomal subunit, where they interact with the 16S rRNA and aminoacyl-tRNA, inhibiting translocation and inducing miscoding. LAR is unaffected by common resistance mechanisms, has a low propensity for generating spontaneous resistance, shows no human cell toxicity, and has potent in vivo activity in a mouse model of Acinetobacter baumannii infection. Our finding of the first ribosome-targeting lasso peptides uncovers new routes toward discovering alternative protein synthesis inhibitors and offers a new chemical scaffold for developing much-needed antibacterial drugs.

An antimicrobial peptide that inhibits translation by trapping release factors on the ribosome

Genome-wide effects of the antimicrobial peptide apidaecin on translation termination in bacteria

Multimodal binding and inhibition of bacterial ribosomes by the antimicrobial peptides Api137 and Api88

Inhibition of translation termination by the antimicrobial peptide Drosocin

Sequence diversity of apidaecin-like peptides arresting the terminating ribosome

A newly-identified mini-hairpin shaped nascent peptide blocks translation termination by a novel mechanism.

Selective inhibition of human translation termination by a drug-like compound

RAPP-containing arrest peptides induce translational stalling by short circuiting the ribosomal peptidyltransferase activity

Structural and mechanistic insights into translation termination

Tetracenomycin X Inhibits Translation by Binding Within the Ribosomal Exit Tunnel

A rationally designed antimicrobial peptide from structural and functional insights of Clostridioides difficile translation initiation factor 1

Paenilamicins are context-specific translocation inhibitors of protein synthesis

Structure-Activity Relationships of the Antimicrobial Peptide Natural Product Apidaecin

Antibacterial Peptide Nucleic Acid-Antimicrobial Peptide (PNA-AMP) Conjugates: Antisense Targeting of Fatty Acid Biosynthesis.

A binding site for the antibiotic GE81112 in the ribosomal mRNA channel

The eRF1 degrader SRI-41315 acts as a molecular glue at the ribosomal decoding center

A Broad Spectrum Lasso Peptide Antibiotic Targeting the Bacterial Ribosome

Macrolide antibiotics allosterically predispose the ribosome for translation arrest.

Targeting nucleic acid phase transitions as a mechanism of action for antimicrobial peptides

Ribosome-inactivation by a class of widely distributed C-tail anchored membrane proteins

Inhibition of Eukaryotic Translation Initiation by the Marine Natural Product Pateamine A